CAS: 1442472-39-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Ripretinib REF: IN-DA01EO7KCAS: 1442472-39-0 | 98% | 48.00 €~614.00 € | Tue 15 Apr 25 |
 | Ripretinib REF: 4Z-R-172001CAS: 1442472-39-0 | - - - | To inquire | Wed 16 Apr 25 |
 | Ripretinib REF: 54-BUP12558CAS: 1442472-39-0 | 99.71% | 2,378.00 €~7,457.00 € | Wed 16 Apr 25 |
 | Ripretinib REF: TM-T8482CAS: 1442472-39-0 | 99.07% | 198.00 €~5,510.00 € | Tue 22 Apr 25 |
 | Ripretinib REF: TR-R295060CAS: 1442472-39-0 | - - - | 16,483.00 € | Tue 27 May 25 |
 | Ripretinib (DCC-2618) REF: 3D-SHC47239CAS: 1442472-39-0 | Min. 95% | - - - | Discontinued product |
Ripretinib
CAS:1442472-39-0
Formula:
C24H21BrFN5O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
510.3582
Ref: IN-DA01EO7K
| 1g | 614.00 € | ||
| 2mg | 48.00 € | ||
| 5mg | 64.00 € | ||
| 10mg | 75.00 € | ||
| 25mg | 109.00 € | ||
| 50mg | 152.00 € | ||
| 100mg | 162.00 € | ||
| 250mg | 285.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025
Ref: 4Z-R-172001
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 16 Apr 2025
Ref: 54-BUP12558
| 25mg | 2,378.00 € | ||
| 50mg | 3,315.00 € | ||
| 100mg | 4,629.00 € | ||
| 200mg | 5,210.00 € | ||
| 500mg | 7,457.00 € |
Estimated delivery in United States, on Wednesday 16 Apr 2025
Ripretinib
CAS:1442472-39-0
Ripretinib (DCC-2618) is an orally bioavailable inhibitor of KIT and PDGFRA.
Formula:
C24H21BrFN5O2
Purity:
99.07%
Color and Shape:
Solid
Molecular weight:
510.36
- Inhibitors
- Apoptosis
- VEGFR
- PDGFR
- See more categories
- c-Kit
Ref: TM-T8482
| 1mg | 399.00 € | ||
| 2mg | 597.00 € | ||
| 5mg | 949.00 € | ||
| 10mg | 1,299.00 € | ||
| 25mg | 1,756.00 € | ||
| 50mg | 2,450.00 € | ||
| 100mg | 3,420.00 € | ||
| 500mg | 5,510.00 € | ||
| 1mL*10mM (DMSO) | 435.00 € |
Estimated delivery in United States, on Tuesday 22 Apr 2025
Ripretinib
Controlled ProductCAS:1442472-39-0
Formula:
C24H21BrFN5O2
Color and Shape:
Neat
Molecular weight:
510.358
Ref: TR-R295060
| 75mg | 16,483.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025
Ripretinib (DCC-2618)
CAS:1442472-39-0
Ripretinib is a potent, orally bioavailable inhibitor of the tyrosine kinase activity of RET. It …
Formula:
C24H21BrFN5O2
Purity:
Min. 95%
Molecular weight:
510.36 g/mol
Ref: 3D-SHC47239
| 1mg | Discontinued | Request information | |
| 2mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
